Terms: = Breast cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Prognosis
23 results:
1. Human study on cancer diagnostic probe (cdp) for real-time excising of breast positive cavity side margins based on tracing hypoxia glycolysis; checking diagnostic accuracy in non-neoadjuvant cases.
Miripour ZS; Abbasvandi F; Aghaee P; Shojaeian F; Faramarzpour M; Mohaghegh P; Hoseinpour P; Namdar N; Hassanpour Amiri M; Ghafari H; Parniani M; Kaviani A; Alamdar S; NajafiKhoshnoo S; Sanati H; Mapar M; Sadeghian N; Akbari ME; Yunesian M; Abdolahad M
Cancer Med; 2022 Apr; 11(7):1630-1645. PubMed ID: 35224879
[TBL] [Abstract] [Full Text] [Related]
2. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
Matsuda Y; Yamashita T; Ye J; Yasukawa M; Yamakawa K; Mukai Y; Machitani M; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Yamada S; Takei J; Kaneko MK; Kojima M; Kaneko S; Masaki T; Hirata M; Haba R; Kontani K; Kanaji N; Miyatake N; Okano K; Kato Y; Masutomi K
J Pathol; 2022 Jun; 257(2):172-185. PubMed ID: 35094384
[TBL] [Abstract] [Full Text] [Related]
3. LEDGF/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators.
Canella A; Van Belle S; Brouns T; Nigita G; Carlon MS; Christ F; Debyser Z
Cancer Gene Ther; 2022 Feb; 29(2):133-140. PubMed ID: 33795806
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analysis of the casp gene family in relation to survival, tumor-infiltrating immune cells and therapeutic targets.
Hong W; Gu Y; Guan R; Xie D; Zhou H; Yu M
Genomics; 2020 Nov; 112(6):4304-4315. PubMed ID: 32682809
[TBL] [Abstract] [Full Text] [Related]
5. HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive breast cancer.
Hosonaga M; Arima Y; Sampetrean O; Komura D; Koya I; Sasaki T; Sato E; Okano H; Kudoh J; Ishikawa S; Saya H; Ishikawa T
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042341
[TBL] [Abstract] [Full Text] [Related]
6. Activator Protein-2β Promotes Tumor Growth and Predicts Poor prognosis in breast cancer.
Li Z; Xu X; Luo M; Hao J; Zhao S; Yu W; Xiao X; Wu J; Zheng F; Chen M; Li Y; Qin G; Liao Y; Zhao X; Yu X; Guo W; Zou L; Deng W
Cell Physiol Biochem; 2018; 47(5):1925-1935. PubMed ID: 29972820
[TBL] [Abstract] [Full Text] [Related]
7. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
8. Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
Takeda T; Yamamoto H; Kanzaki H; Suzawa K; Yoshioka T; Tomida S; Cui X; Murali R; Namba K; Sato H; Torigoe H; Watanabe M; Shien K; Soh J; Asano H; Tsukuda K; Kitamura Y; Miyoshi S; Sendo T; Toyooka S
PLoS One; 2017; 12(2):e0171356. PubMed ID: 28158234
[TBL] [Abstract] [Full Text] [Related]
9. Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients.
Ahmad F; Badwe A; Verma G; Bhatia S; Das BR
Med Oncol; 2016 Jul; 33(7):74. PubMed ID: 27282497
[TBL] [Abstract] [Full Text] [Related]
10. Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231.
De Blasio A; Di Fiore R; Morreale M; Carlisi D; Drago-Ferrante R; Montalbano M; Scerri C; Tesoriere G; Vento R
Int J Oncol; 2016 Jun; 48(6):2339-48. PubMed ID: 27082853
[TBL] [Abstract] [Full Text] [Related]
11. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
[TBL] [Abstract] [Full Text] [Related]
12. Cyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growth.
Zhou Y; Han C; Li D; Yu Z; Li F; Li F; An Q; Bai H; Zhang X; Duan Z; Kan Q
Sci Rep; 2015 May; 5():10433. PubMed ID: 25990212
[TBL] [Abstract] [Full Text] [Related]
13. Recent progress in HER2 associated breast cancer.
Wang WJ; Lei YY; Mei JH; Wang CL
Asian Pac J Cancer Prev; 2015; 16(7):2591-600. PubMed ID: 25854334
[TBL] [Abstract] [Full Text] [Related]
14. A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.
Rafiq S; Khan S; Tapper W; Collins A; Upstill-Goddard R; Gerty S; Blomqvist C; Aittomäki K; Couch FJ; Liu J; Nevanlinna H; Eccles D
PLoS One; 2014; 9(12):e101488. PubMed ID: 25526632
[TBL] [Abstract] [Full Text] [Related]
15. Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failure.
Sansregret L; Vadnais C; Livingstone J; Kwiatkowski N; Awan A; Cadieux C; Leduy L; Hallett MT; Nepveu A
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1949-54. PubMed ID: 21245318
[TBL] [Abstract] [Full Text] [Related]
16. PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer.
Carvalho S; Milanezi F; Costa JL; Amendoeira I; Schmitt F
Virchows Arch; 2010 Mar; 456(3):235-43. PubMed ID: 20130907
[TBL] [Abstract] [Full Text] [Related]
17. TrkC: a new predictive marker in breast cancer?
Blasco-Gutiérrez MJ; José-Crespo IJ; Zozaya-Alvarez E; Ramos-Sánchez R; García-Atarés N
Cancer Invest; 2007 Sep; 25(6):405-10. PubMed ID: 17882651
[TBL] [Abstract] [Full Text] [Related]
18. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract] [Full Text] [Related]
19. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM
Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
[TBL] [Abstract] [Full Text] [Related]
20. Expression of nerve growth factor receptors and their prognostic value in human breast cancer.
Descamps S; Pawlowski V; Révillion F; Hornez L; Hebbar M; Boilly B; Hondermarck H; Peyrat JP
Cancer Res; 2001 Jun; 61(11):4337-40. PubMed ID: 11389056
[TBL] [Abstract] [Full Text] [Related]
[Next]
